COVID-19 and anosmia: A review based on up-to-date knowledge
X Meng, Y Deng, Z Dai, Z Meng - American journal of otolaryngology, 2020 - Elsevier
Abstract The pandemic of Coronavirus Disease 2019 (COVID-19) has caused a vast
disaster throughout the world. There is increasing evidence that olfactory dysfunction can …
disaster throughout the world. There is increasing evidence that olfactory dysfunction can …
Neurological and neuropsychiatric impacts of COVID-19 pandemic
D Roy, R Ghosh, S Dubey, MJ Dubey… - Canadian Journal of …, 2021 - cambridge.org
Background: Albeit primarily a disease of respiratory tract, the 2019 coronavirus infectious
disease (COVID-19) has been found to have causal association with a plethora of …
disease (COVID-19) has been found to have causal association with a plethora of …
The role of Neuropilin-1 in COVID-19
BS Mayi, JA Leibowitz, AT Woods, KA Ammon… - PLoS …, 2021 - journals.plos.org
Neuropilin-1 (NRP-1), a member of a family of signaling proteins, was shown to serve as an
entry factor and potentiate SARS Coronavirus 2 (SARS-CoV-2) infectivity in vitro. This cell …
entry factor and potentiate SARS Coronavirus 2 (SARS-CoV-2) infectivity in vitro. This cell …
The impact of pre-existing comorbidities and therapeutic interventions on COVID-19
LA Callender, M Curran, SM Bates… - Frontiers in …, 2020 - frontiersin.org
Evidence from the global outbreak of SARS-CoV-2 has clearly demonstrated that individuals
with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of …
with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of …
Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19–positive patients compared to subjective methods: A systematic review …
ME Hannum, VA Ramirez, SJ Lipson… - Chemical …, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …
SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain
L Fodoulian, J Tuberosa, D Rossier, M Boillat, C Kan… - Iscience, 2020 - cell.com
Reports indicate an association between COVID-19 and anosmia, as well as the presence
of SARS-CoV-2 virions in the olfactory bulb. To test whether the olfactory neuroepithelium …
of SARS-CoV-2 virions in the olfactory bulb. To test whether the olfactory neuroepithelium …
Поражение нервной системы при СOVID-19
ВВ Белопасов, Я Яссин, ЕМ Самойлова… - Клиническая …, 2020 - cyberleninka.ru
В статье на основе имеющихся публикаций систематизированы сведения об основных
формах поражения периферической и центральной нервной систем, их клинических …
формах поражения периферической и центральной нервной систем, их клинических …
Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI
MFVV Aragão, MC Leal… - American Journal …, 2020 - Am Soc Neuroradiology
Patients with coronavirus disease 2019 (COVID-19) may have symptoms of anosmia or
partial loss of the sense of smell, often accompanied by changes in taste. We report 5 cases …
partial loss of the sense of smell, often accompanied by changes in taste. We report 5 cases …
[PDF][PDF] Olfactory dysfunction in the COVID-19 outbreak
A Izquierdo-Dominguez, MJ Rojas-Lechuga… - J Investig Allergol Clin …, 2020 - jiaci.org
The first cases of coronavirus 2019 (COVID-19) occurred in Wuhan, China, and rapidly
become a public health emergency of international proportions. The disease may cause …
become a public health emergency of international proportions. The disease may cause …
Diagnosing COVID‐19 in the emergency department: a scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases
Objective Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) emerged as a
global pandemic in early 2020 with rapidly evolving approaches to diagnosing the clinical …
global pandemic in early 2020 with rapidly evolving approaches to diagnosing the clinical …